Overview

A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes

Status:
Completed

Trial end date:
2017-12-21

Target enrollment:

Participant gender:

Summary

A cardiac safety study of an investigational drug to see how it affects the heart in people with Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Phase:

Phase 2

Details

Lead Sponsor:

Sunovion

Treatments:

Apomorphine
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination